TERN
Terns Pharmaceuticals Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Terns Pharmaceuticals specializes in the research and development of therapies in hepatology, particularly for the treatment of NASH.
Terns Pharmaceuticals Inc
TERN
Terns Pharmaceuticals specializes in the research and development of therapies in hepatology, particularly for the treatment of NASH.
Price history of Terns Pharmaceuticals Inc
Price history of Terns Pharmaceuticals Inc
Performance & Momentum
Terns Pharmaceuticals surges on positive TERN-701 Phase 1 data
In October 2025, Terns Pharmaceuticals reported highly positive Phase 1 results for its TERN-701 treatment targeting chronic myeloid leukemia (CML). The study showed a major molecular response rate of 75% at 24 weeks with good tolerance and no dose-limiting toxicity. These promising data, selected for an oral presentation at a major hematology conference, signal a strategic shift for the company from metabolic disorders to oncology. Additionally, stock options were granted to new employees under an incentive plan, indicating strong internal momentum. This clinical success may boost Terns' market valuation and attract investor interest in its CML treatment prospects.
Strategic Analysis
Terns Pharmaceuticals Inc • 2026
Terns Pharmaceuticals is positioned as an innovative player in biotechnology, focused on developing cutting-edge therapies in hepatology, particularly for the treatment of NASH, a disease with a significant unmet medical need. Its model is based on targeted research and advanced clinical development, offering differentiated potential in a high-growth segment.
- Deep expertise in hepatology and liver diseases
- Strong valuation growth reflecting increased market confidence
- Positioning in a rapidly expanding addressable market
- Dependence on clinical outcomes and regulatory approvals
- Lack of geographic or sector diversification
Exceptional momentum reflects strong investor enthusiasm, driven by promising progress in its clinical programs and disruptive potential in the treatment of NASH. This dynamic supports high visibility, but also calls for caution regarding the delivery of expected results.
Similar stocks to Terns Pharmaceuticals Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
